| Title : A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure - Asakawa_2009_Life.Sci_85_122 |
| Author(s) : Asakawa T , Moritoh Y , Kataoka O , Suzuki N , Takeuchi K , Odaka H |
| Ref : Life Sciences , 85 :122 , 2009 |
| Abstract : |
| PubMedSearch : Asakawa_2009_Life.Sci_85_122 |
| PubMedID: 19427871 |
| Title : The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob\/ob mice - Moritoh_2009_Eur.J.Pharmacol_602_448 |
| Author(s) : Moritoh Y , Takeuchi K , Asakawa T , Kataoka O , Odaka H |
| Ref : European Journal of Pharmacology , 602 :448 , 2009 |
| Abstract : |
| PubMedSearch : Moritoh_2009_Eur.J.Pharmacol_602_448 |
| PubMedID: 19038243 |
| Title : Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice - Moritoh_2008_Eur.J.Pharmacol_588_325 |
| Author(s) : Moritoh Y , Takeuchi K , Asakawa T , Kataoka O , Odaka H |
| Ref : European Journal of Pharmacology , 588 :325 , 2008 |
| Abstract : |
| PubMedSearch : Moritoh_2008_Eur.J.Pharmacol_588_325 |
| PubMedID: 18499100 |